Microarray analysis of fresh tumor samples from human pancreatic cancer patients implanted into severely combined immunodeficient (SCID) mice revealed that FERMT1 mRNA was increased in patient-derived xenograft (PDX) tumors compared to normal mice [37]. This evidence concerns the gene FERMT1 and pancreatic neoplasm.